Investigating the (Cost-)Effectiveness of an Online Social Therapy Platform (ENYOY) for Young People Aged 16-25 on Mental Healthcare Waiting Lists (ENYOY:nextstep)
13 de maio de 2026 atualizado por: Prof. Dr. Arne Popma, Academisch Medisch Centrum - Amsterdam UMC Research BV
ENgage YOung People earlY: the Next Steps
This study, run by Amsterdam UMC in the Netherlands, looks at whether an online mental health platform called ENYOY can help improve psychological distress in young people (16-25) who are waiting for mental health care. Young people in the Netherlands aged 16 to 25 can take part if they are experiencing mental health problems, and are currently on a waiting list for mental healthcare. The study lasts 12 months. During this time, participants fill in questionnaires four times (at the start, at 3-months, 6-months, and 12-months). After joining the study, participants are randomly placed into one of two groups:
- Intervention group: receives access to the ENYOY platform plus care-as-usual.
- Control group: receive care-as-usual. Young people in the intervention group can use the platform for the duration of the study period, with three months of guidence by a coach and/or peer with lived experience with mental health complaints. The platform includes activities based on proven psychological methods. These activities help with things like low mood, anxiety, sleep problems, and confidence. They also get support from a coach and/or a peer (someone who has experienced mental health problems themselves), and access to a safe online community where young people can talk, share experiences, and support each other. The community is moderated to keep it safe and supportive. Taking part may help young people feel psychological stress and improve their mental health. There are no known risks from taking part in this study.
Participant recruitment will take place from May 2026 to December 2027. Final follow-up assessments are expected to be completed by December 2028. The study is funded by ZonMw. For questions, you can contact Sascha Struijs (s.y.struijs@vu.nl), or Fenna Hellegers (f.hellegers@amsterdamumc.nl)
Visão geral do estudo
Status
Ainda não está recrutando
Condições
Intervenção / Tratamento
Descrição detalhada
This study aims to evaluate the (cost-)effectiveness of a digital health platform (ENYOY) in reducing psychological distress among young people experiencing mental health difficulties who are currently on a waiting list for mental healthcare.
Outcomes will be compared between participants who receive access to ENYOY in addition to care-as-usual and those receiving care-as-usual alone.
Dutch young people aged 16 to 25 years who report mental health difficulties and are currently on a waiting list for mental healthcare services are eligible to participate.
Participants will complete self-report questionnaires at four time points (at the start, at 3-months, 6-months, and 12-months) over a 12-month period.
Following baseline assessment, participants will be randomly allocated to either the intervention condition (ENYOY plus care-as-usual) or the control condition (care-as-usual only).
Participants in the intervention group will receive access to the ENYOY platform, including guidance from a coach and/or a peer with lived experience of mental health difficulties for three months.
The platform provides personalised, self-directed therapeutic content, and access to a moderated online peer community.
Participants in the control group will continue to receive standard care.
Participation may contribute to a reduction in psychological distress and improvements in mental health outcomes.
No adverse health risks are anticipated.
The study is conducted by Amsterdam UMC, in the Netherlands.
Participant recruitment will take place from May 2026 to December 2027.
Final follow-up assessments are expected to be completed by December 2028.
This study is funded by ZonMw.
For further information, please contact Sascha Struijs (s.y.struijs@vu.nl)
or Fenna Hellegers (f.hellegers@amsterdamumc.nl).
Tipo de estudo
Intervencional
Inscrição (Estimado)
225
Estágio
- Não aplicável
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Age 16-25 years
- On a waiting list for mental healthcare
- Able and willing to consent
- A score of 10 or higher on the CORE-10 questionnaire
- Have personal and private access to a computer, smartphone or tablet.
- Ability and willingness to nominate an emergency contact person, such as a close family member
Exclusion Criteria:
- Insufficient command of the Dutch language
- Present with acute suicidal behavior or imminent risk of harm to self
- If their psychiatric symptoms are due to an organic cause
- Prior exposure to ENYOY or MOST
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Experimental condition
Young people in this group receive access to the ENYOY platform, along with three months of guidance from a coach and/or a peer with lived experience of mental health difficulties, in addition to Care-As-Usual.
|
ENYOY is an evidence-based digital mental health platform co-created with young people. It combines four main elements: interactive therapeutic content, guidence by coaches and/or peers with lived experience with mental health complaints, and a moderated online community. The therapeutic content is based on approaches like cognitive behavioral therapy and is tailored into "journeys" that match a young person's needs, such as improving mood, reducing anxiety, or building confidence. Users can explore activities and build a personal toolkit. The online community offers young people a safe social space where young people can connect, share experiences, and support each other. Engagement is encouraged through discussions, prompts, and optional anonymous participation. Safety is closely monitored through both human moderation and automated systems that detect risk.
Outros nomes:
|
|
Outro: Control condition
Young people in the control condition receive Care As Asual.
|
Young people in the control condition receive Care As Usual.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Psychological distress
Prazo: At 3-month follow-up
|
Psychological distress will be measured using the Clinical Outcomes in Routine Evaluation-10 measurement (Barkham et al., 2013).
The minimum score is 0 and the maximum score is 40.
Higher scores indicate higher levels of psychological distress.
|
At 3-month follow-up
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Psychological distress
Prazo: At 6-, and 12-month follow-up
|
Psychological distress will be measured using the Clinical Outcomes in Routine Evaluation-10 measurement (Barkham et al., 2013).
The minimum score is 0 and the maximum score is 40.
Higher scores indicate higher levels of psychological distress.
|
At 6-, and 12-month follow-up
|
|
Functioning
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Functioning will be measured using Work and Social Adjustment Scale - youth version (WSAS-Y; Jassi et al., 2020).
The minimum score is 0 and the maximum score is 40.
Higher scores indicate greater impairment in functioning.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Quality of life
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Quality of life will be measured using the My Life Tracker measurement (MLT; Kwan et al., 2018).
The minimum score is 0 and the maximum score is 100.
Higher scores indicate a better quality of life.
We will also use the Co-created outcome measure (YAG, YOUTHreach consortium).
The minimum score is 0 and the maximum score is 124.
Higher scores indicate a higher quality of life.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Depression
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Depression will be measured using the Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001).
The minimum score is 0 and the maximum is 27.
Higher scores indicate a higher level of depression.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Anxiety
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Anxiety will be measured using the Generalized Anxiety Disorder questionnaire-7 (GAD-7; Spitzer et al., 2006).
The minimum score is 0 and the maximum score is 21.
Higher scores indicate a higher level of anxiety.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Self-esteem
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Self-esteem will be measured using the Rosenberg Self-Esteem Scale questionnaire (RSES; Rosenberg, 1965).
The minimum score is 0 and the maximum score is 30.
Higher scores indicate a higher self-esteem.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Health economic measure
Prazo: at 3-month, 6-months, and 12-month follow-up
|
Health economic measures will be using the EuroQol - 5 Dimensions - 5 Levels measurement (EQ-5D-5L;EuroQol Research Foundation, 2025; Herdman et al., 2011).
The minimum score from the vife dimensions is 11111 and the maximum score is 55555.
Higer scores indicate a better health status.
We will also use a Resource Use Measurement developed by the YOUTHreach consortium to indicate the resourced used by the young person (RUM; YOUTHreach consortium).
|
at 3-month, 6-months, and 12-month follow-up
|
|
Social media use
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Social media use will be measured using 8 items of the Compulsive Internet Use Scale (CIUS; Meerkerk et al. 2009).
The minimum score is 0 and the maximum score is 32.
Higher scores indicate a higher social media usage.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Lonliness
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Lonliness will be measured using the University of California, Los Angeles (UCLA) Loneliness Scale short form (V3; Russell, 1996).
The minimum score is 8 and the maximum score is 32.
A higher score indicate greater levels of lonliness.
|
at 3-month, 6-month, and 12-month follow-up
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Reach
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Reach will be measured using the number of individuals consenting to, participating in, initiating ENYOY, and dropping out during the intervention period.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Adoption
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Adoption will be measured using the number and profile of sites and delivery agents trained and actively delivering ENYOY during the intervention period.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Implementation
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Implementation will be measured by the extent to which ENYOY components are delivered and used as intended, using structured checklists and platform-derived usage data.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Implementation
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Implementation will be measured using the User Version of the Mobile Application Rating Scale (uMARS; Stoyanov et al., 2016).
The minimum score is 1 and the maximum score is 5. Higher score indicate a higher quality of the application.
Additionally, a bespoke ENYOY satisfaction measure will be used.
|
at 3-month, 6-month, and 12-month follow-up
|
|
Maintenance
Prazo: at 3-month, 6-month, and 12-month follow-up
|
Maintenance will be measured using ENYOY platform-derived usage data and intended continuation of ENYOY use using self-report items.
|
at 3-month, 6-month, and 12-month follow-up
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Estimado)
18 de maio de 2026
Conclusão Primária (Estimado)
31 de dezembro de 2028
Conclusão do estudo (Estimado)
31 de dezembro de 2028
Datas de inscrição no estudo
Enviado pela primeira vez
6 de maio de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
13 de maio de 2026
Primeira postagem (Real)
19 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
19 de maio de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
13 de maio de 2026
Última verificação
1 de maio de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- NL-010792
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
SIM
Descrição do plano IPD
Pseudonymized research data from the individual research participants will be shared with the YOUTHReach consortium.
See attachment for the registration of their study.
Sharing IPD with other researchers is possible upon request.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .